BioSyent Declares Second Quarter 2023 Dividend
25 mai 2023 17h40 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 25, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly...
BioSyent Schedules Q1 2023 Earnings Release for May 26, 2023
18 mai 2023 08h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months ended March 31, 2023 on...
FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians, Eight Years Running!
02 mai 2023 14h59 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, May 02, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based...
FeraMAXᴹᴰ est le 1er choix de supplément de fer recommandé par les pharmaciens et les médecins canadiens, pour la huitième année consécutive!
02 mai 2023 14h59 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, 02 mai 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (« BioSyent », Bourse de croissance TSX : RX) a le plaisir d’annoncer que FeraMAXMD est le 1er choix de marque de supplément de...
BioSyent to Present at 2023 Bloom Burton & Co. Healthcare Investor Conference
18 avr. 2023 09h15 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, April 18, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2023 Bloom Burton & Co....
BioSyent Announces Grant of Restricted Share Units
31 mars 2023 17h42 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 31, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 72,020...
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2022
21 mars 2023 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 21, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and twelve months ended December 31, 2022. Key...
BioSyent Schedules Q4 and Full Year 2022 Earnings Release for March 21, 2023
09 mars 2023 16h30 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended...
BioSyent annonce le lancement du nouveau FeraMAX(MD) Pd Entretien 45
07 mars 2023 16h01 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, 07 mars 2023 (GLOBE NEWSWIRE) -- À la veille de la Journée internationale des femmes, BioSyent Inc. (« BioSyent », « la Société », « Bourse de croissance TSX » : RX) célèbre le...
BioSyent Announces Launch of New FeraMAX® Pd Maintenance 45
07 mars 2023 16h01 HE
|
BioSyent Inc.
MISSISSAUGA, Ontario, March 07, 2023 (GLOBE NEWSWIRE) -- On the eve of International Women’s Day, BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) celebrates the Canadian launch of...